Frequencies and predictors of subcutaneous and intraosseous injection with four epinephrine autoinjector devices.
Fiche publication
Date publication
mai 2024
Journal
Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology
Auteurs
Membres identifiés du Cancéropôle Est :
Dr GOETZ Christophe
Tous les auteurs :
Lefevre S, Goetz C, Hennequin L, Zevering Y, Dinot V
Lien Pubmed
Résumé
To prevent anaphylaxis-associated illness, intramuscular-epinephrine injection is recommended. Subcutaneous injection may reduce efficacy and intraosseous injection promotes morbidity. A few studies suggest that commercially-available thigh-epinephrine autoinjectors (EAIs) may induce subcutaneous/intraosseous injection in some adults.
Mots clés
Epinephrine autoinjector, female sex, intraosseous injection, skin to muscle depth, subcutaneous injection
Référence
Ann Allergy Asthma Immunol. 2024 05 11;: